RecruitingNot applicableNCT07084142

Developing a Digital Aid to Improve ICD Decisions

Studying Hereditary persistence of fetal hemoglobin-sickle cell disease syndrome

Last synced from ClinicalTrials.gov

Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing data

Key facts

Sponsor
Stanford University
Principal Investigator
Randall S Stafford, MD, PhD
Stanford University
Intervention
Online, patient-facing decision-making aid (app) with personalized risk information.(other)
Enrollment
600 target
Eligibility
60 years · All sexes
Timeline
20252028

Study locations (2)

Collaborators

National Heart, Lung, and Blood Institute (NHLBI) · University of California, San Francisco · East Carolina University

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT07084142 on ClinicalTrials.gov

Other trials for Hereditary persistence of fetal hemoglobin-sickle cell disease syndrome

Additional recruiting or active studies for the same condition.

See all trials for Hereditary persistence of fetal hemoglobin-sickle cell disease syndrome

← Back to all trials